Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of SK-1403 ; Double-blinded Parallel Group in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

NCT03801980 is registered in ClinicalTrials.gov with Sanwa Kagaku Kenkyusho Co., Ltd. as lead sponsor.

NCT NCT03801980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03801980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of SK-1403 ; Double-blinded Parallel Group in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis
Lead sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
January 21, 2019
Completion date
December 21, 2019
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary hyperparathyroidism